IQVIA Holdings Inc.
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)
Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –
Iqvia Capital Expenditures by Quarter
Capital Expenditures (Additions to Property, Equipment & Software) ($M)
Iqvia Capital Expenditures: $158M in Q3 2026, up 16.2% from a year earlier.
Latest, Q3 2026
158
Period ended Sep 30, 2026
Change on a year earlier
+16.2%
136 in Q3 2025
History
59 quarters
Since Q1 2012
Sources
51
Documents cited below
Where the Q3 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Iqvia Capital Expenditures ($M), quarterly Q1 2012–Q3 2026 [Data set]. Compiled from Iqvia SEC filings and investor materials. https://stockdatahq.com/stocks/iqv/kpis/db-capex
See every metric in the Iqvia KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?